Luca Santarelli Selected Research

Luca Santarelli Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 02/2012
4	Schizophrenia (Dementia Praecox) 08/2014 - 05/2014
3	Infections 07/2005 - 12/2002
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2018 - 12/2012
2	Inflammation (Inflammations) 02/2012 - 07/2005
2	Migraine Disorders (Migraine) 03/2003 - 05/2002
1	Achondroplasia 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Mental Disorders (Mental Disorder) 01/2018
1	Psychotic Disorders (Schizoaffective Disorder) 01/2018
1	Hallucinations (Hallucination) 01/2018
1	Dementia (Dementias) 01/2017
1	Cognitive Dysfunction 05/2014
1	Autism Spectrum Disorder 10/2013
1	Neurofibromatoses (Neurofibromatosis) 12/2012
1	Autistic Disorder (Autism) 12/2012
1	Rett Syndrome (Rett's Disorder) 12/2012
1	Neurodevelopmental Disorders 12/2012
1	Edema (Dropsy) 02/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2011
1	Acute Coronary Syndrome 07/2005
1	Dyspepsia (Indigestion) 11/2004
1	Halitosis 09/2003
1	Bile Reflux 09/2003
1	Pain (Aches) 09/2003
1	Gastritis 09/2003
1	Heartburn (Pyrosis) 09/2003
1	Klinefelter Syndrome (Klinefelter's Syndrome) 08/2003
1	Sex Chromosome Disorders 08/2003
1	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2003
1	Rhabdomyolysis 04/2003
1	Hepatitis C 04/2003
1	Mood Disorders (Mood Disorder) 01/2002

Drug/Important Bio-Agent (IBA)

3	gantenerumabIBA 01/2018 - 02/2012
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 08/2014 - 05/2014
2	N- ((3S)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1H- indazole- 3- carboxamide hydrochlorideIBA 06/2014 - 05/2014
2	Pharmaceutical PreparationsIBA 10/2013 - 12/2012
2	Urea (Carbamide)FDA LinkGeneric 07/2005 - 12/2002
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020
1	2- chloro- 4- (1- (4- fluorophenyl)- 2,5- dimethyl- 1H- imidazol- 4- ylethynyl)pyridineIBA 01/2018
1	Metabotropic Glutamate 5 ReceptorIBA 01/2018
1	sembragilineIBA 01/2017
1	Memantine (Namenda)FDA Link 01/2017
1	Monoamine Oxidase (MAO)IBA 01/2017
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2017
1	Paliperidone Palmitate FDA Link 06/2014
1	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2014
1	Antipsychotic Agents (Antipsychotics)IBA 06/2014
1	Aripiprazole (Abilify)FDA Link 06/2014
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 06/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2014
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 05/2014
1	Cholinergic Agents (Cholinergics)IBA 05/2014
1	Monoclonal AntibodiesIBA 02/2012
1	Amyloid (Amyloid Fibrils)IBA 02/2012
1	Cell Adhesion MoleculesIBA 07/2005
1	Azithromycin (Zithromax)FDA LinkGeneric 07/2005
1	MineralsIBA 11/2004
1	Mineral WatersIBA 11/2004
1	SaltsIBA 11/2004
1	Sucralfate (Carafate)FDA LinkGeneric 09/2003
1	Rabeprazole (Aciphex)FDA Link 09/2003
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2003
1	InterferonsIBA 04/2003
1	AntibodiesIBA 05/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2002
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2002
1	Substance PIBA 01/2002
1	gamma-Aminobutyric Acid (GABA)IBA 01/2002
1	NeuropeptidesIBA 01/2002

Therapy/Procedure

5	Therapeutics 10/2013 - 04/2003
1	Drug Therapy (Chemotherapy) 11/2004
1	Cholecystectomy 09/2003
1	Gluten-Free Diet 03/2003